TMS Co., Ltd.

4891・Growth Market・Pharmaceuticals

Official website

TMS Co., Ltd.

4891・Growth Market・Pharmaceuticals

Official website

TMS Co., Ltd.4891

Reference Indicators

Market Cap

46¥100M

P/E (Forecast)

—

P/B

1.7x

Dividend Yield (Forecast)

0.00%

ROE

-23.7%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2023Feb 2023	2024Feb 2024	2025Feb 2025
Operating Income	-520	-943	-907
Non-operating Income	0	3	342
Non-operating Expenses	341	3	67
Ordinary Income	-861	-943	-633
Extraordinary Losses	—	15	26
Pre-tax Income	-861	-959	-659
Income Taxes	-0	0	0
Net Income	-860	-960	-660
EBITDA	-513	-936	-904
ROA	-22.7%	-27.0%	-21.8%
ROE	-27.9%	-26.8%	-23.7%